Skip to content

Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During Total Knee Arthroplasty (TKA)

Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During Total Knee Arthroplasty

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02286739
Enrollment
500
Registered
2014-11-10
Start date
2015-04-30
Completion date
2020-05-31
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Total Knee Arthroplasty, Rotational Alignment, Intraoperative Sensors, Patient Outcomes, Soft Tissue Balance

Brief summary

The objectives of the study are twofold: 1) Evaluate how intra-operative sensing may assist the surgeon with tibiofemoral rotational alignment by testing the precision and variability of setting tray rotation to the mid-third of the tibial tubercle. 2) Understand if patients with a combined axial rotation couple at the tibiofemoral joint and quantitative intercompartmental balance, achieved with the use of VERASENSE, exhibit less post-operative knee pain and improved clinical outcomes. Radiographic outcomes will also be assessed to measure post-operative alignment and to evaluate the prevalence and location of radiolucency and/or osteolysis.

Detailed description

Hypothesis: TKA with VERASENSE results in a more reliable and precise option for establishing implant-to-implant congruency and joint balance leading to less knee pain, faster return to normal activities and higher patient satisfaction compared to TKA without VERASENSE.

Interventions

DEVICETKA with Verasense

VERASENSE replaces the standard tibial trial inserts and is embedded with microelectronics and sensors to provide surgeons with real-time knee kinetic data. The data is wirelessly transmitted to a graphic display (VERASENSE Knee Application), allowing surgeons to quantify and assess soft tissue intercompartmental loads throughout the range of motion. The VERASENSE sensor is not an investigational device. OrthoSensor, Inc., received FDA pre-market submission (510K) clearance in 2009. The indication for use is a tool for adjustment of the femoral knee implant to reduce instability from flexion gap asymmetry. The VERASENSE sensor is sterile and single patient use.

PROCEDURETKA without Verasense

TKA will be performed manually without the use of Verasense

Sponsors

Orthosensor, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients who meet the indications for use for Triathlon® Total Knee System using VERASENSE™ * Subject must be diagnosed with one or more of the following conditions * osteoarthritis * rheumatoid or other inflammatory arthritis * post-traumatic arthritis * Subject is likely to be available for all study visits * Subject is able and willing to sign the informed consent and follow study procedures

Exclusion criteria

* Prior Total Knee Arthroplasty * Avascular Necrosis * Any knee surgery other than meniscectomy (can be arthroscopic or open) * Ligament insufficiencies, prior surgeries such as anterior cruciate ligament (ACL) or PCL reconstructions, posterolateral reconstructions, osteotomies, tibia plateau fractures * Ipsilateral foot/ankle and hip arthritis * Range of motion less than 90°, flexion contracture greater than 20° * Subject has a mental condition that may interfere with the subject's ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the Subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the Subject's cognitive abilities, senile dementia, and Alzheimer's Disease) * Any subjects meeting any contraindication criteria as identified in the locally approved labeling for the device should be excluded from this study.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Quantitatively Balanced and Unbalanced Knees in Primary Unilateral Total Knee ArthroplastyIntra-operative with trial implants in place and after completing all surgical corrections.Evaluate how intra-operative sensing with VERASENSE may assist the surgeon with balancing. A load differential of up to 15 pound (lbs) or less between the medial and lateral condyles is indicative of soft-tissue balance. A load differential more than 15 lbs is indicative for soft-tissue unbalance.

Secondary

MeasureTime frameDescription
Knee Society Knee Scoring Systempre-operative, 6 weeks, 6 months, 1 year, 2 yearsPatient Satisfaction is a three-question 40-point scale and has a score of 0 (not satisfied) to 40 (very satisfied) that is collected preoperatively and at each follow-up visit. Patient Expectations is a five-question fifteen-point scale and has a score of 0 (low expectation) to 15 (high expectation) that is collected pre-operatively and post-operatively. The pre-operative questions reflect the patient's opinion on the extent to which the patient expects that the operation will improve their knee pain, and their ability to perform their activities of daily living and recreational activities. The post-operative questions reflect the extent to which the outcome after the operation has met the patient's pre-operative expectations with respect to pain and function. The functional score is composed of four subgroups (Walking and standing, standard activities, advanced activities, discretionary activities) and has a score of 0 (poor) to 100 (excellent).
Investigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).Pre-operative, 6 weeks, 6 months, 1 year and 2 yearsThe EQ-5D Time Trade-off (TTO) descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/comfort and anxiety/depression. Each dimension has three levels: no problems, some problems and extreme problems. The scores range from -0.59 (worst possible health state) to 1 (best possible health state).
Forgotten Joint Score (FJS)6 weeks, 6 months, 1 year, 2 yearsThe FJS is based on the patients' ability to forget about a joint as a result of the treatment. The FJS assessment is scored on a 0-100 scale. The higher the score, the less the patient is aware of their affected joint when performing daily activities.

Countries

United States

Participant flow

Participants by arm

ArmCount
Group A TKA Without VERASENSE
patients who undergo primary PCL-retaining or - sacrificing TKA without the use of VERASENSE to guide rotational alignment and balance. TKA without Verasense: TKA will be performed manually without the use of Verasense
170
Group B TKA With VERASENSE
patients who undergo primary PCL-retaining or - sacrificing TKA with the use of VERASENSE to guide rotational alignment and balance. TKA with Verasense: VERASENSE replaces the standard tibial trial inserts and is embedded with microelectronics and sensors to provide surgeons with real-time knee kinetic data. The data is wirelessly transmitted to a graphic display (VERASENSE Knee Application), allowing surgeons to quantify and assess soft tissue intercompartmental loads throughout the range of motion. The VERASENSE sensor is not an investigational device. OrthoSensor, Inc., received FDA 510K clearance in 2009. The indication for use is a tool for adjustment of the femoral knee implant to reduce instability from flexion gap asymmetry. The VERASENSE sensor is sterile and single patient use.
162
Total332

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event12
Overall StudyLost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified86112
Overall StudyNo Verasense type documented023
Overall StudyVerasense type posterior stabilizing (PS)3716

Baseline characteristics

CharacteristicGroup A TKA Without VERASENSEGroup B TKA With VERASENSETotal
Age, Continuous67.29 years
STANDARD_DEVIATION 8.42
68.06 years
STANDARD_DEVIATION 8.12
67.73 years
STANDARD_DEVIATION 8.25
Body Mass Index (BMI)31.29 kg / m^2
STANDARD_DEVIATION 6.65
31.11 kg / m^2
STANDARD_DEVIATION 6.27
31.20 kg / m^2
STANDARD_DEVIATION 6.46
Race/Ethnicity, Customized
African American or Black
19 Participants22 Participants41 Participants
Race/Ethnicity, Customized
Asian
0 Participants3 Participants3 Participants
Race/Ethnicity, Customized
Hispanic or Latino
6 Participants6 Participants12 Participants
Race/Ethnicity, Customized
Other
4 Participants2 Participants6 Participants
Race/Ethnicity, Customized
White
105 Participants109 Participants214 Participants
Sex: Female, Male
Female
112 Participants101 Participants213 Participants
Sex: Female, Male
Male
58 Participants59 Participants117 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1700 / 162
other
Total, other adverse events
0 / 1700 / 162
serious
Total, serious adverse events
8 / 1706 / 162

Outcome results

Primary

Number of Participants With Quantitatively Balanced and Unbalanced Knees in Primary Unilateral Total Knee Arthroplasty

Evaluate how intra-operative sensing with VERASENSE may assist the surgeon with balancing. A load differential of up to 15 pound (lbs) or less between the medial and lateral condyles is indicative of soft-tissue balance. A load differential more than 15 lbs is indicative for soft-tissue unbalance.

Time frame: Intra-operative with trial implants in place and after completing all surgical corrections.

Population: Data was not collected for all participants. Numbers analyzed represent evaluable cases.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Group A TKA Without VERASENSENumber of Participants With Quantitatively Balanced and Unbalanced Knees in Primary Unilateral Total Knee ArthroplastyParticipants with balanced knee65 Participants
Group A TKA Without VERASENSENumber of Participants With Quantitatively Balanced and Unbalanced Knees in Primary Unilateral Total Knee ArthroplastyParticipants with unbalanced knee68 Participants
Group B TKA With VERASENSENumber of Participants With Quantitatively Balanced and Unbalanced Knees in Primary Unilateral Total Knee ArthroplastyParticipants with balanced knee103 Participants
Group B TKA With VERASENSENumber of Participants With Quantitatively Balanced and Unbalanced Knees in Primary Unilateral Total Knee ArthroplastyParticipants with unbalanced knee20 Participants
Secondary

Forgotten Joint Score (FJS)

The FJS is based on the patients' ability to forget about a joint as a result of the treatment. The FJS assessment is scored on a 0-100 scale. The higher the score, the less the patient is aware of their affected joint when performing daily activities.

Time frame: 6 weeks, 6 months, 1 year, 2 years

Population: Data was not collected for all participants. Numbers analyzed represent evaluable cases.

ArmMeasureGroupValue (MEAN)Dispersion
Group A TKA Without VERASENSEForgotten Joint Score (FJS)FJS 6 months55.11 units on a scaleStandard Deviation 26.89
Group A TKA Without VERASENSEForgotten Joint Score (FJS)FJS 6 weeks30.55 units on a scaleStandard Deviation 25.52
Group A TKA Without VERASENSEForgotten Joint Score (FJS)FJS 1 year57.88 units on a scaleStandard Deviation 28.23
Group A TKA Without VERASENSEForgotten Joint Score (FJS)FJS 2 years59.78 units on a scaleStandard Deviation 32.22
Group B TKA With VERASENSEForgotten Joint Score (FJS)FJS 2 years65.73 units on a scaleStandard Deviation 31.11
Group B TKA With VERASENSEForgotten Joint Score (FJS)FJS 6 months55.46 units on a scaleStandard Deviation 26.77
Group B TKA With VERASENSEForgotten Joint Score (FJS)FJS 1 year60.34 units on a scaleStandard Deviation 27.35
Group B TKA With VERASENSEForgotten Joint Score (FJS)FJS 6 weeks33.31 units on a scaleStandard Deviation 27.88
Secondary

Investigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).

The EQ-5D Time Trade-off (TTO) descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/comfort and anxiety/depression. Each dimension has three levels: no problems, some problems and extreme problems. The scores range from -0.59 (worst possible health state) to 1 (best possible health state).

Time frame: Pre-operative, 6 weeks, 6 months, 1 year and 2 years

Population: Data was not collected for all participants. Numbers analyzed represent evaluable cases.

ArmMeasureGroupValue (MEAN)Dispersion
Group A TKA Without VERASENSEInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).EQ-5D TTO pre-operative0.66 units on a scaleStandard Deviation 0.18
Group A TKA Without VERASENSEInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).EQ-5D TTO 6 weeks0.75 units on a scaleStandard Deviation 0.18
Group A TKA Without VERASENSEInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).EQ-5D TTO 6 months0.87 units on a scaleStandard Deviation 0.14
Group A TKA Without VERASENSEInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).EQ-5D TTO 1 year0.86 units on a scaleStandard Deviation 0.18
Group A TKA Without VERASENSEInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).EQ-5D TTO 2 years0.86 units on a scaleStandard Deviation 0.14
Group B TKA With VERASENSEInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).EQ-5D TTO 2 years0.73 units on a scaleStandard Deviation 0.18
Group B TKA With VERASENSEInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).EQ-5D TTO 1 year0.87 units on a scaleStandard Deviation 0.13
Group B TKA With VERASENSEInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).EQ-5D TTO pre-operative0.63 units on a scaleStandard Deviation 0.19
Group B TKA With VERASENSEInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).EQ-5D TTO 6 months0.85 units on a scaleStandard Deviation 0.16
Group B TKA With VERASENSEInvestigation of Clinical Performance and Patient Outcome With the EuroQuol-5 Dimension Health Questionnaire (EQ-5D).EQ-5D TTO 6 weeks0.78 units on a scaleStandard Deviation 0.15
Secondary

Knee Society Knee Scoring System

Patient Satisfaction is a three-question 40-point scale and has a score of 0 (not satisfied) to 40 (very satisfied) that is collected preoperatively and at each follow-up visit. Patient Expectations is a five-question fifteen-point scale and has a score of 0 (low expectation) to 15 (high expectation) that is collected pre-operatively and post-operatively. The pre-operative questions reflect the patient's opinion on the extent to which the patient expects that the operation will improve their knee pain, and their ability to perform their activities of daily living and recreational activities. The post-operative questions reflect the extent to which the outcome after the operation has met the patient's pre-operative expectations with respect to pain and function. The functional score is composed of four subgroups (Walking and standing, standard activities, advanced activities, discretionary activities) and has a score of 0 (poor) to 100 (excellent).

Time frame: pre-operative, 6 weeks, 6 months, 1 year, 2 years

Population: Data was not collected for all participants. Numbers analyzed represent evaluable cases.

ArmMeasureGroupValue (MEAN)Dispersion
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemSatisfaction Score 6 months31.11 units on a scaleStandard Deviation 8.71
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemExpectations 6 months10.01 units on a scaleStandard Deviation 2.82
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemSatisfaction Score pre-operative13.61 units on a scaleStandard Deviation 6.94
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemExpectations 1 year10.28 units on a scaleStandard Deviation 3.08
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemSatisfaction Score 1 year32.44 units on a scaleStandard Deviation 8.48
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemExpectations 2 years10.69 units on a scaleStandard Deviation 3.35
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemFunctional Score pre-operative36.75 units on a scaleStandard Deviation 15.88
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemSatisfaction Score 2 years32.15 units on a scaleStandard Deviation 7.9
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemFunctional Score 6 weeks 6 weeks44.84 units on a scaleStandard Deviation 19.02
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemSatisfaction Score 6 weeks26.20 units on a scaleStandard Deviation 7.93
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemFunctional Score 6 months69.25 units on a scaleStandard Deviation 19.24
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemFunctional Score 1 year71.82 units on a scaleStandard Deviation 17.34
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemExpectations 6 weeks9.62 units on a scaleStandard Deviation 2.72
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemFunctional Score 2 years68.69 units on a scaleStandard Deviation 18.65
Group A TKA Without VERASENSEKnee Society Knee Scoring SystemExpectations Score pre-operative14.30 units on a scaleStandard Deviation 1.4
Group B TKA With VERASENSEKnee Society Knee Scoring SystemFunctional Score 2 years69.77 units on a scaleStandard Deviation 18.29
Group B TKA With VERASENSEKnee Society Knee Scoring SystemSatisfaction Score pre-operative13.35 units on a scaleStandard Deviation 6.85
Group B TKA With VERASENSEKnee Society Knee Scoring SystemSatisfaction Score 6 weeks26.45 units on a scaleStandard Deviation 8.28
Group B TKA With VERASENSEKnee Society Knee Scoring SystemSatisfaction Score 6 months31.30 units on a scaleStandard Deviation 8.93
Group B TKA With VERASENSEKnee Society Knee Scoring SystemSatisfaction Score 1 year32.98 units on a scaleStandard Deviation 8.22
Group B TKA With VERASENSEKnee Society Knee Scoring SystemSatisfaction Score 2 years33.21 units on a scaleStandard Deviation 7.32
Group B TKA With VERASENSEKnee Society Knee Scoring SystemExpectations Score pre-operative14.19 units on a scaleStandard Deviation 1.48
Group B TKA With VERASENSEKnee Society Knee Scoring SystemExpectations 6 weeks9.50 units on a scaleStandard Deviation 2.74
Group B TKA With VERASENSEKnee Society Knee Scoring SystemExpectations 6 months9.92 units on a scaleStandard Deviation 2.89
Group B TKA With VERASENSEKnee Society Knee Scoring SystemExpectations 1 year10.44 units on a scaleStandard Deviation 3.04
Group B TKA With VERASENSEKnee Society Knee Scoring SystemExpectations 2 years10.81 units on a scaleStandard Deviation 3.25
Group B TKA With VERASENSEKnee Society Knee Scoring SystemFunctional Score pre-operative37.13 units on a scaleStandard Deviation 16.11
Group B TKA With VERASENSEKnee Society Knee Scoring SystemFunctional Score 6 weeks 6 weeks46.73 units on a scaleStandard Deviation 18.91
Group B TKA With VERASENSEKnee Society Knee Scoring SystemFunctional Score 6 months68.95 units on a scaleStandard Deviation 19.03
Group B TKA With VERASENSEKnee Society Knee Scoring SystemFunctional Score 1 year72.44 units on a scaleStandard Deviation 17.09

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026